Cingulate Stock Performance

CING Stock  USD 4.76  0.22  4.42%   
Cingulate has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -1.08, which signifies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Cingulate are expected to decrease slowly. On the other hand, during market turmoil, Cingulate is expected to outperform it slightly. Cingulate right now shows a risk of 5.96%. Please confirm Cingulate sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Cingulate will be following its price patterns.

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Cingulate may actually be approaching a critical reversion point that can send shares even higher in February 2025. ...more

Actual Historical Performance (%)

One Day Return
(4.42)
Five Day Return
2.15
Year To Date Return
(6.67)
Ten Year Return
(99.55)
All Time Return
(99.55)
Last Split Factor
1:12
Last Split Date
2024-08-09
1
Cingulate Reports Third Quarter 2024 Financial ResultsReflecting 19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
11/07/2024
2
Cingulate Raised to Buy at Maxim Group
11/21/2024
3
Acquisition by Lawrence Bryan Jay of 5000 shares of Cingulate at 1.18 subject to Rule 16b-3
11/25/2024
4
Acquisition by Van Horn Louis G of 50000 shares of Cingulate at 1.79 subject to Rule 16b-3
12/23/2024
5
Acquisition by Brams Matthew of 1000 shares of Cingulate at 4.93 subject to Rule 16b-3
12/31/2024
6
Final Study Completed for Cingulates Lead Asset CTx-1301
01/07/2025
7
Acquisition by Werth Peter J. of 687043 shares of Cingulate at 1.0E-4 subject to Rule 16b-3
01/17/2025
Begin Period Cash Flow5.4 M
  

Cingulate Relative Risk vs. Return Landscape

If you would invest  492.00  in Cingulate on October 20, 2024 and sell it today you would lose (16.00) from holding Cingulate or give up 3.25% of portfolio value over 90 days. Cingulate is currently generating 0.1079% in daily expected returns and assumes 5.9571% risk (volatility on return distribution) over the 90 days horizon. In different words, 53% of stocks are less volatile than Cingulate, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Cingulate is expected to generate 7.07 times more return on investment than the market. However, the company is 7.07 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.03 per unit of risk.

Cingulate Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cingulate's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cingulate, and traders can use it to determine the average amount a Cingulate's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0181

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskCINGHuge Risk
Negative Returns

Estimated Market Risk

 5.96
  actual daily
53
53% of assets are less volatile

Expected Return

 0.11
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.02
  actual daily
1
99% of assets perform better
Based on monthly moving average Cingulate is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cingulate by adding it to a well-diversified portfolio.

Cingulate Fundamentals Growth

Cingulate Stock prices reflect investors' perceptions of the future prospects and financial health of Cingulate, and Cingulate fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cingulate Stock performance.

About Cingulate Performance

By analyzing Cingulate's fundamental ratios, stakeholders can gain valuable insights into Cingulate's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cingulate has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cingulate has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand(10.53)(10.00)
Return On Tangible Assets(7.75)(7.36)
Return On Capital Employed 3.04  3.19 
Return On Assets(7.75)(7.36)
Return On Equity 3.08  3.24 

Things to note about Cingulate performance evaluation

Checking the ongoing alerts about Cingulate for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cingulate help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cingulate had very high historical volatility over the last 90 days
Cingulate has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (23.53 K) with loss before overhead, payroll, taxes, and interest of (15.49 M).
Cingulate currently holds about 8.2 M in cash with (15.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Cingulate has a poor financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Acquisition by Werth Peter J. of 687043 shares of Cingulate at 1.0E-4 subject to Rule 16b-3
Evaluating Cingulate's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cingulate's stock performance include:
  • Analyzing Cingulate's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cingulate's stock is overvalued or undervalued compared to its peers.
  • Examining Cingulate's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cingulate's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cingulate's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cingulate's stock. These opinions can provide insight into Cingulate's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cingulate's stock performance is not an exact science, and many factors can impact Cingulate's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Cingulate Stock analysis

When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Share Portfolio
Track or share privately all of your investments from the convenience of any device